Jouni Jokela, David P. Fewer, Cheryl A. Kerfeld, Thierry Laurent, Jörn Piel, Muriel Gugger, Alexandra Calteau, Amel Latifi, Thérèse Coursin, Kaarina Sivonen, Génomique métabolique (UMR 8030), Genoscope - Centre national de séquençage [Evry] (GENOSCOPE), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université d'Évry-Val-d'Essonne (UEVE)-Centre National de la Recherche Scientifique (CNRS), Department of Food and Environmental Sciences, University of Helsinki, Laboratoire de chimie bactérienne (LCB), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Collection des Cyanobactéries, Institut Pasteur [Paris], Department of Plant and Microbial Biology [Berkeley], University of California [Berkeley], University of California-University of California, MSU-DOE Plant Research Laboratory and Department of Biochemistry and Molecular Biology, Michigan State University [East Lansing], Michigan State University System-Michigan State University System, Institute of Microbiology, Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), Funding was provided by the Institut Pasteur, a grantby the EU (BlueGenics) to JP, a grant by the US Department of Energy (DE-AC02 05CH11231) to CAK and Academy of Finland grants (118637, 258827)to KS and DPF (259505) as well as University of Helsinki grant to DPF(490085)., European Project: 311848,EC:FP7:KBBE,FP7-KBBE-2012-6-singlestage,BLUEGENICS(2012), Helsingin yliopisto = Helsingfors universitet = University of Helsinki, Institut Pasteur [Paris] (IP), University of California [Berkeley] (UC Berkeley), University of California (UC)-University of California (UC), Department of Food and Nutrition, Microbial Natural Products, and Cyanobacteria research
Background Cyanobacteria are an ancient lineage of photosynthetic bacteria from which hundreds of natural products have been described, including many notorious toxins but also potent natural products of interest to the pharmaceutical and biotechnological industries. Many of these compounds are the products of non-ribosomal peptide synthetase (NRPS) or polyketide synthase (PKS) pathways. However, current understanding of the diversification of these pathways is largely based on the chemical structure of the bioactive compounds, while the evolutionary forces driving their remarkable chemical diversity are poorly understood. Results We carried out a phylum-wide investigation of genetic diversification of the cyanobacterial NRPS and PKS pathways for the production of bioactive compounds. 452 NRPS and PKS gene clusters were identified from 89 cyanobacterial genomes, revealing a clear burst in late-branching lineages. Our genomic analysis further grouped the clusters into 286 highly diversified cluster families (CF) of pathways. Some CFs appeared vertically inherited, while others presented a more complex evolutionary history. Only a few horizontal gene transfers were evidenced amongst strongly conserved CFs in the phylum, while several others have undergone drastic gene shuffling events, which could result in the observed diversification of the pathways. Conclusions Therefore, in addition to toxin production, several NRPS and PKS gene clusters are devoted to important cellular processes of these bacteria such as nitrogen fixation and iron uptake. The majority of the biosynthetic clusters identified here have unknown end products, highlighting the power of genome mining for the discovery of new natural products. Electronic supplementary material The online version of this article (doi:10.1186/1471-2164-15-977) contains supplementary material, which is available to authorized users.